RESUMEN

BACKGROUND: Population health studies often use existing databases that are not necessarily constituted for research purposes. The question arises as to whether different data sources such as in administrative health data (AHD) and self-report questionnaires are equivalent and lead to similar information. OBJECTIVES: The main objective of this study was to assess the level of agreement between self-reported medical conditions and medical diagnosis captured in AHD. A secondary objective was to identify predictors of agreement among medical conditions between the two data sources. Therefore, the purposes of the study were to explore the extent to which these two methods of commonly used public health data collection provide concordant records and identify the main predictors of statistical variations. METHODS: Data were extracted from CARTaGENE, a population-based cohort in Québec, Canada, which was linked to the provincial health insurance records of the same individuals, namely the MED-ÉCHO database from the Régie de l'assurance maladie du Québec (RAMQ) and the fee-for-service billing records provided by the physician, for the time period 1998-2012. Agreement statistics (kappa coefficient) along with sensitivity, specificity and predictive positive value were calculated for 19 chronic conditions and 12 types of cancers. Logistic regressions were used to identify predictors of concordance between self-report and AHD from significant covariates (sex, age groups, education, region, income, heavy utilization of health care system and Charlson comorbidity index). RESULTS: Agreement between self-reported data and AHD across diseases ranged from kappa of 0.09 for chronic renal failure to 0.86 for type 2 diabetes. Sensitivity of self-reported data was higher than 50% for 14 out of the 31 medical conditions studied, especially for myocardial infarction (88.62%), breast cancer (86.28%), and diabetes (85.06%). Specificity was generally high with a minimum value of 89.70%. Lower concordance between data sources was observed for higher frequency of health care utilization and higher comorbidity scores. CONCLUSION: Overall, there was moderate agreement between the two data sources but important variations were found depending on the type of disease. This suggests that CARTaGENE's participants were generally able to correctly identify the kind of diseases they suffer from, with some exceptions. These results may help researchers choose adequate data sources according to specific study objectives. These results also suggest that Québec's AHD seem to underestimate the prevalence of some chronic conditions, which might result in inaccurate estimates of morbidity with consequences for public health surveillance.

RESUMEN

PURPOSE: To predict sulcus size using ocular measurements. SETTING: Michel Pop Clinics, Montreal, Quebec, Canada. METHODS: Forty-three eyes were evaluated using several techniques. Ultrasound biomicroscopy (UBM) echograms were taken to measure the anterior chamber depth (ACD), sulcus size, and central corneal thickness. The limbus size was measured with a caliper. Axial length, ACD, and pachymetry were measured by contact ultrasonography. Refraction and corneal power were also evaluated. RESULTS: The coefficient of linear regression was 0.05 between the limbus and the sulcus size (P =.78), 0.76 between ultrasonography and UBM ACD measurements (P <.001), and 0.69 between ultrasonography and UBM pachymetry (P <.001). Paired t tests showed that ultrasound and UBM ACD measurements were not statistically different (P =.70) but that ultrasound and UBM pachymetry measurements were (P <.001). The sulcus versus limbus difference was 0.6 mm for myopia and 0.3 mm for hyperopia. A backward elimination multiple regression performed with all measures to predict sulcus size resulted in the following formula: Sulcus size = 18.9 - 0.023 x sphere + 0.15 x mean keratometry (R = 0.49; P =.005; statistical power = 0.89; standard error of estimate = 0.5 mm). CONCLUSION: Traditional estimation of sulcus size through limbal measurement is inadequate because limbus size alone cannot predict sulcus size. A general formula using the sphere and the mean corneal power can help predict sulcus size. Corneal power was significantly and negatively correlated with sulcus and limbus size as well as sphere. The standard error of sulcus measurement by UBM was 0.4 mm.

Asunto(s)

RESUMEN

OBJECTIVE: To study photorefractive keratectomy (PRK) or laser in situ keratomileusis (LASIK) after clear lens extraction (CLE) with intraocular lens (IOL) implantation for hyperopia or astigmatism. DESIGN: Retrospective, noncomparative interventional case series. PARTICIPANTS: Sixty-five eyes (55 subjects) had CLE with posterior chamber IOL implants for hyperopia up to 12.25 diopters (D); 31 eyes were retreated with PRK, and 34 eyes were retreated with LASIK for residual ametropias. INTERVENTION: For PRK and LASIK, the refractive surgery was performed with the slit-scanning excimer laser Nidek EC-5000, Nidek Co., Tokyo, Japan. MAIN OUTCOME MEASURES: Manifest refraction, best-spectacle and uncorrected Snellen visual acuity, haze, and halos were evaluated before surgery and at 1, 3, 6, and 12 months postoperative. RESULTS: Forty-seven eyes were evaluated at the 12-month postoperative examination: 96% of these eyes had spherical equivalents (SE) within +/-2 D of emmetropia, 79% of eyes had SE within +/-1 D of emmetropia and 51% of eyes had SE within +/-0.50 D of emmetropia. Eighty-five percent of the eyes at 12 months postoperative had uncorrected visual acuity of 20/40 or better, and 46% of eyes had uncorrected visual acuity of 20/20 or better. Eighty-seven percent of the eyes at 12 months postoperative had uncorrected visual acuity within 1 Snellen line of their initial best spectacle-corrected visual acuity (BSCVA) before all treatment. No eye lost 2 Snellen lines of BSCVA at 3, 6, or 12 months after PRK or after LASIK. CONCLUSIONS: IOL implantation for CLE, although an invasive technique, resulted in better refractive outcomes without laser-related clinical complications after PRK or LASIK adjustment.

Asunto(s)

RESUMEN

OBJECTIVE: To study the refraction and potential risks of bilateral photorefractive keratectomy for myopia. DESIGN: Retrospective, noncomparative case series. PARTICIPANTS: Four hundred eighteen consecutive patients (836 eyes) with myopia from -18 to -0.50 diopters (D) had bilateral simultaneous refractive surgery. INTERVENTION: Refractive surgery was performed with the Nidek EC-5000 slit-scanning excimer laser (Nidek Co., Tokyo, Japan). MAIN OUTCOME MEASURES: Manifest refraction, Snellen best spectacle-corrected visual acuity (BSCVA) and uncorrected visual acuity, haze, and halos were evaluated for 12 months after surgery. Both eyes of each patient were examined at the same follow-up after initial treatment. RESULTS: At 12 months after surgery, 95% of eyes were within +/- 1D of emmetropia, and 0.4% of patients had residual anisometropia more than 2 D. Thirty-three eyes (3.9%) were retreated, whereas 5 patients (1.2%) had retreatments in both eyes. Odds ratios between unilateral versus bilateral postoperative events were evaluated for the retreatments (1:0.22; P = 0.001), undercorrections more than 1 D (1:0.17; P < 0.0001), overcorrections more than 1 D (1:0.23; P < 0.0001), loss of 1 line of BSCVA (1:0.44; P < or = 0.002), and loss of 2 lines of BSCVA (1:0.18; P = 0.013). At 12 months after surgery, one eye with a loss of 2 lines of BSCVA was treated for haze more than 1; the fellow eye had haze 0.75. No patient had bilateral haze more than 1. At 12 months after surgery, no patient lost 2 lines of BSCVA in both eyes. There was a higher incidence of halos in both eyes rather than in one eye only (odds ratio: 4.17; P < 0.0001). No postoperative infections occurred. CONCLUSIONS: Bilateral events occurred approximately 2.5 to 4 times less often than unilateral events, except for the incidence of halos. The calculated odds ratio did not show an increased risk for the fellow eye while performing bilateral surgery, although not exempted from the risk of infection. It may be difficult to predict a complication in the fellow eye based on the results of the first operated eye.

Asunto(s)

RESUMEN

OBJECTIVE: Photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) outcomes were compared at 1, 3, 6, and 12 months after surgery. DESIGN: Retrospective, nonrandomized, comparative study. PARTICIPANTS: One hundred seven LASIK-treated eyes (58 patients) and 107 PRK-treated eyes (91 patients) having myopia between -1 and -9.50 diopters (D). All LASIK-treated eyes were analyzed retrospectively and matched with PRK-treated eyes having sphere within +/-0.25 D, +/-1 D of cylinder, and +/-7 years of age. INTERVENTION: For PRK and LASIK, the refractive surgery was performed with the slit-scanning excimer laser Nidek EC-5000, (Nidek Co. Tokyo, Japan) MAIN OUTCOME MEASURES: Manifest refraction, best-spectacle and uncorrected Snellen visual acuity, haze, halos, and keratometry were evaluated before surgery and up to 12 months after surgery. RESULTS: Seventy percent of eyes were evaluated at the 12-month postoperative exam. Of these eyes, 83% of LASIK cases and 86% of PRK cases had uncorrected visual acuities of 20/20 or better. Refractions within +/-0.5 D represented 78% of the LASIK eyes and 83% of the PRK eyes at that follow-up. Patients who underwent LASIK reported halos twice as often as patients who underwent PRK using a subjective scale. The odds ratio of high halos for LASIK versus PRK was 3.50 (95% confidence interval, 1.89-6.46; P<0.0001). At 1 month after surgery, 64% of the LASIK eyes were within +/-0.50 D compared with 77% of the PRK eyes. No eye lost 2 Snellen lines of best corrected visual acuity at 6 or 12 months after surgery. Ten PRK eyes (9.3%) and three LASIK eyes (2.8%) were retreated. CONCLUSIONS: PRK and LASIK achieved equal refractive outcomes at all postoperative follow-ups, but LASIK patients were twice as likely to experience halos.

Asunto(s)

RESUMEN

PURPOSE: To study the in situ relative intraocular position of the Ophtec Artisan iris-claw phakic intraocular lens (PIOL) for high myopia using ultrasound biomicroscopy. METHODS: Three PIOLs (13.00, 17.00 and 18.00 D lens powers) were implanted in phakic myopic eyes. Using ultrasound biomicroscopy, echograms were taken in the anterior chamber to measure the preoperative anterior chamber depth, postoperative distance between the PIOL and the corneal endothelium (endothelial-optic distance), and the postoperative distance between the PIOL and the crystalline lens. RESULTS: Preoperative anterior chamber depth ranged from 3.10 to 3.40 mm and the postoperative endothelial-optic distance measured 2.11 to 2.44 mm. The distance between the crystalline lens and the posterior surface of the IOL ranged from 0.78 to 0.93 mm. Several echograms revealed the position of the PIOL on the iris. The pigment layer of the iris did not seem to be disturbed by the presence of the PIOL. CONCLUSION: The original anterior chamber depths were reduced by 28% to 34% after implantation. The PIOL-crystalline lens distance ranged from 0.78 to 0.93 mm. This study of 3 eyes revealed that echograms taken by ultrasound biomicroscopy are useful in verifying the intraocular position of the PIOL within the anterior chamber.

Asunto(s)

RESUMEN

PURPOSE: To study photorefractive keratectomy (PRK) for high myopia using the Nidek EC-5000 slit scanning laser and to compare a single pass versus a multipass ablation approach. METHODS: We retrospectively studied 95 eyes (64 patients; range -10.00 to -27.00 D; mean -12.00 D) treated for high myopia using PRK with a single or multipass technique. Forty-two eyes were treated with the single pass technique and 53 eyes were treated with the multipass technique. RESULTS: Twelve months after PRK, 79.4% (27 eyes) of the multipass group and 48.1% (13 eyes) of the single pass group were within +/-1.00 D of emmetropia; 32.4% (11 eyes) of multipass eyes and 29.6% (8 eyes) of single pass eyes were within +/-0.50 D of emmetropia. Uncorrected visual acuity of 20/40 or better was reached by 85.3% (29 eyes) and 20/20 or better was reached by 55.9% (19 eyes) in the multipass group at 12 months postoperatively. For the single pass group, 74.1% (20 eyes) achieved 20/40 uncorrected and 18.5% (5 eyes) achieved 20/20 uncorrected visual acuity. No multipass-treated eyes lost 2 lines of spectacle-corrected visual acuity at 6 or 12 months postoperatively. Mean regression between 1 to 12 months after PRK was 0.46 D for the multipass group and 1.45 D for the single pass group. Most of the regression occurred within the first 6 months after surgery in both techniques. CONCLUSION: These PRK results showed that treating high myopia using the Nidek EC-5000 excimer laser combined with a multipass approach generated good refractive outcomes with no complications. Undercorrections with the single pass technique could be compensated for with new nomograms. The multipass technique resulted in less regression and better refractive outcomes.

Asunto(s)

RESUMEN

BACKGROUND: Recent studies have raised the hypothesis that glucocorticoids could diminish the ability of endothelial cells to direct leukocyte traffic into inflamed tissues by inhibiting expression of the adhesion molecules endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. The aim of the present study was to investigate whether glucocorticoids also regulate the expression of L-selectin and CD11/CD18 integrins on human neutrophil granulocytes. METHODS AND RESULTS: Incubation of human whole blood with platelet-activating factor (PAF, 1 mumol/L) evoked downregulation of L-selectin and upregulation of CD11/CD18 adhesion receptors on neutrophils as measured by flow cytometry. While dexamethasone (0.1 nmol/L to 100 mumol/L) did not affect expression of adhesion molecules on resting neutrophils, it attenuated the PAF-induced changes in L-selectin and CD18 expression in a time- and concentration-dependent fashion with IC50 values of 31 and 13 nmol/L, respectively. These effects of dexamethasone were completely aborted by RU-486 (10 mumol/L), which blocks transcriptional activation of the glucocorticoid receptor, and by the protein synthesis inhibitor cycloheximide (35.5 mumol/L). Dexamethasone, up to a concentration of 1 mumol/L, neither affected significantly the release of granule enzymes nor interfered with PAF binding to its membrane receptors. CONCLUSIONS: Our results show that glucocorticoids at clinically relevant concentrations exert specific actions on expression of adhesion molecules on activated neutrophils, which are mediated through ligation of glucocorticoid receptors and induction of protein synthesis, and suggest a novel mechanism by which anti-inflammatory corticosteroids may inhibit leukocyte accumulation.

Asunto(s)

RESUMEN

Relationships between in vitro cadmium-related cell cytotoxicity, ultrastructural changes and altered cell cycle were determined at 21-72 h after mitogenic stimulation of C57BL/6 mouse spleen lymphocytes with concanavalin A (Con A). Relatively low doses, 0.6-10 microM cadmium (Cd), added at 4 h after the mitogen activation, induced a significant cell cytotoxicity and reduced the lymphoblastic activity of the cells. Cytometric analysis of the lymphoid cell cycle at 72 h revealed that at concentrations > or = 0.6 microM Cd, the number of cells arrested in G0 + G1 phase increased, whereas the proportions of cells of the S and G2 + M phases were substantially reduced. Staining of cells with fluorescent anti-CD25 monoclonal antibody showed a cadmium-related decreased number and relative mean fluorescence of CD25+ cells, demonstrating a decreased level of interleukin-2 receptor (IL-2R). Furthermore, immunogold ultramicroscopic assay was developed for determination of intracellular interleukin-2 (IL-2) in cadmium-treated lymphocytes. The level of cytoplasmic and nuclear IL-2, localized in situ by colloidal gold ultraimmunocytochemical technique, has been estimated as markedly decreased in cells treated with > or = 1.2 microM Cd, as compared with the untreated controls. Disorganization/fragmentation of mitochondrion cristae and dilatation of cisternae of the Golgi apparatus appeared as the major ultrastructural change in 1.2 microM Cd-treated lymphocytes. Interestingly, addition of cadmium in the incubation medium, up to 4 h after mitogen activation, also interacted with lymphoproliferative mechanisms of cells in G0 + G1, S and G2 + M phase. Overall, multiple ultrastructural changes of Cd-treated lymphoid cells were clearly related with the reduced cell viability and reduced number of activated lymphoblasts.

Asunto(s)